AstriVax Therapeutics Initiates Clinical Development of AVX70371, a Hepatitis B immunotherapy using Launch-iT technology
Third asset to advance into clinical trials, validating broad potential of Launch-iT…
Halia Therapeutics Completes Enrollment in Phase 2a Clinical Trial of HT-6184 for Myelodysplastic Syndrome (MDS)
LEHI, Utah, June 4, 2025 /PRNewswire/ -- Halia Therapeutics, a clinical-stage biopharmaceutical…
Cartesian Therapeutics Announces New Employment Inducement Grants
June 03, 2025 07:05 ET | Source: Cartesian Therapeutics, Inc. FREDERICK, Md.,…
